ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,700.00
-340.00 (-3.39%)
At close: Feb 6, 2026

ImmuneOncia Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.000.010.010.000.000.00
Asset Turnover
-0.020.000.180.000
Quick Ratio
7.363.007.757.164.8013.22
Current Ratio
8.183.067.907.534.8413.31
Return on Equity (ROE)
--22.97%----
Return on Assets (ROA)
--26.25%-21.22%-21.71%-18.57%-22.71%
Return on Capital Employed (ROCE)
-55.30%-63.90%-38.80%-47.30%-28.10%-46.10%
Buyback Yield / Dilution
-27.73%-7.35%-0.64%-12.17%-904.47%0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.